(Q44231742)

1 December 2017

title

HIV-1 and IL-1 beta regulate Fas ligand expression in human astrocytes through the NF-kappa B pathway (English)

1 reference

1 December 2017

0 references

0 references

1 reference

3

1 reference

1 December 2017

Ghorpade A

1

1 reference

1 December 2017

Holter S

series ordinal

2

1 reference

1 December 2017

Persidsky R

series ordinal

4

1 reference

1 December 2017

Wu L

series ordinal

5

1 reference

1 December 2017

publication date

1 August 2003

1 reference

Journal of Neuroimmunology

1 December 2017

published in

1 reference

1 December 2017

volume

141

1 reference

1 December 2017

issue

1-2

1 reference

1 December 2017

page(s)

141-149

1 reference

Fas (CD95) expression on CD4+ T cells from HIV-infected patients increases with disease progression

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Early T-cell apoptosis and Fas expression during antiretroviral therapy in individuals infected with human immunodeficiency virus-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Integration of the NF-kappaB and mitogen-activated protein kinase/AP-1 pathways at the collagenase-1 promoter: divergence of IL-1 and TNF-dependent signal transduction in rabbit primary synovial fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Fas expression on human fetal astrocytes without susceptibility to fas-mediated cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Astrocyte-induced T cell elimination is CD95 ligand dependent.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Expression of Fas and Fas ligand after experimental traumatic brain injury in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Upregulated expression of Fas and Fas ligand in brain through the spectrum of HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Detectable concentrations of Fas ligand in cerebrospinal fluid after severe head injury

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Co-expression of Fas and Fas ligand in human non-astrocytic glial tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Human immunodeficiency virus neurotropism: an analysis of viral replication and cytopathicity for divergent strains in monocytes and microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

1 reference

7 January 2021

Efficient synthesis of viral nucleic acids following monocyte infection by HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Concentrations of soluble CD95 and CD8 antigens in the plasma and levels of CD8+CD95+, CD8+CD38+, and CD4+CD95+ T cells are markers for HIV-1 infection and clinical status

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Differential regulation and function of Fas expression on glial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

NF-kappaB regulation in the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas/FasL, but not the perforin pathway,.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

The soluble form of Fas molecule is elevated in parkinsonian brain tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Increased CD95/Fas-induced apoptosis of HIV-specific CD8(+) T cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Fas antigen expression in brains of patients with Alzheimer-type dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Nuclear factor-kappaB activates dual inhibition sites in the regulation of tumor necrosis factor-alpha-induced neutrophil apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Soluble Fas/APO-1 in tumor cells: a potential regulator of apoptosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Microglial and astrocyte chemokines regulate monocyte migration through the blood-brain barrier in human immunodeficiency virus-1 encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Review: neuronal injury in HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Elevated levels of soluble Fas and Fas ligand in cerebrospinal fluid of patients with AIDS dementia complex.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Apoptosis of CD4+ and CD19+ cells during human immunodeficiency virus type 1 infection--correlation with clinical progression, viral load, and loss of humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

The restricted nature of HIV-1 tropism for cultured neural cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

The role of interleukin-converting enzyme in Fas-mediated apoptosis in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Increased levels of soluble Fas receptor and Fas ligand in the cerebrospinal fluid of HIV-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Apoptosis-resistant T cells have a deficiency in NF-kappaB-mediated induction of Fas ligand transcription.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Promoter independent down-regulation of the firefly luciferase gene by T3 and T3 receptor in CV1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Cytokine expression in the brain during the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

A novel signaling mechanism for soluble CD95 ligand. Synergy with anti-CD95 monoclonal antibodies for apoptosis and NF-kappaB nuclear translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Immunobiology of tumor necrosis factor receptor superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

Intrathecal Fas ligand infusion strengthens immunoprivilege of central nervous system and suppresses experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900222-4

7 January 2021

10.1016/S0165-5728(03)00222-4

Identifiers

DOI

1 reference

1 December 2017

1 reference